Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 83 Leukemia, Myeloid, Chronic-Phase 23 Leukemia 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Gastrointestinal Stromal Tumors 14 Blast Crisis 7 Neoplasms 6 Neoplasm Metastasis 6 Philadelphia Chromosome 4 Myeloproliferative Disorders 4 Recurrence 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Bone Marrow Diseases 3 Synovitis, Pigmented Villonodular 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Leukemia, Myeloid, Accelerated Phase 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Sarcoma 1 Retroperitoneal liposarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Peritoneal Neoplasms 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1

Interventions

Doxorubicin 22 Radiotherapy 12 Ifosfamide 11 Trabectedin 10 pazopanib 5 Gemcitabine 5 ribociclib 4 pembrolizumab 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 palbociclib 3 eribulin 3 X-Rays 3 Imatinib Mesylate 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 romidepsin 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡